Formation of a statewide community pharmacy practice-based research network: Pharmacist opinions on research participation and engagement

2020 ◽  
Vol 60 (6) ◽  
pp. 951-956
Author(s):  
Jenny S. Li ◽  
Victoria Blake ◽  
Samantha George ◽  
Joni C. Carroll ◽  
Melissa A. Somma McGivney ◽  
...  
2012 ◽  
Vol 3 (2) ◽  
Author(s):  
Margie E. Snyder ◽  
Caitlin K. Frail ◽  
Lindsey V. Seel ◽  
Kyle E. Hultgren

In 2010, the Purdue University College of Pharmacy established the Medication Safety Research Network of Indiana (Rx-SafeNet), the first practice-based research network (PBRN) in Indiana comprised solely of community pharmacies. In the development of Rx-SafeNet and through our early project experiences, we identified several "lessons learned." We share our story and what we learned in an effort to further advance the work of the greater PBRN community. We have formed the infrastructure for Rx-SafeNet, including an Executive Committee, Advisory Board, member pharmacies/site coordinators, and Project Review Team. To date, 22 community pharmacies have joined and we have recently completed data collection for the network's first project. Lessons learned during the development of Rx-SafeNet may benefit PBRNs nationally. Although community pharmacy PBRNs are not yet commonplace in the U.S., we believe their development and subsequent research efforts serve as an important avenue for investigating medication use issues.   Type: Idea Paper


2015 ◽  
Vol 6 (2) ◽  
Author(s):  
Mary Ann Kozak ◽  
Stephanie A. Gernant ◽  
Heather M. Hemmeger ◽  
Margie E. Snyder

Community pharmacy practice-based research networks (CP PBRNs) are a relatively new arena for pharmacists. While some lessons may be gleaned from primary care PBRNs, the experiences of CP PBRNs have much to offer the profession in terms of organization and practice. In 2012, we reported on our early experiences developing the Medication Safety Research Network of Indiana (RxSafeNet) after establishing the Network in 2010. Over the past 3 years, our CP PBRN of approximately 180 members has managed further growth by revisiting policies and procedures, maintaining CP PBRN member relationships, and preparing for financial sustainability. We look forward to furthering our CP PBRN projects in the coming years and collaborating with other CP PBRNs to enhance medication safety in Indiana and beyond.   Type: Original Research


Pharmacy ◽  
2019 ◽  
Vol 7 (3) ◽  
pp. 118
Author(s):  
Joni C. Carroll ◽  
Melissa Somma McGivney ◽  
Kim C. Coley

Community pharmacies across the United States are forming clinically integrated networks (CINs) to facilitate the provision of patient-centered care. These networks need to continually innovate and demonstrate how their patient care services positively impact health outcomes. One way to do this is to develop a practice-based research network (PBRN) in partnership with existing CINs to perform robust outcome evaluations. The objective of this study was to learn pharmacists’ opinions on participating in research to facilitate the formation of a community pharmacy PBRN in Pennsylvania. A 20-item survey gathered information on pharmacists’ research interests, perceived benefits of research participation, and preferences on communication and patient engagement. Descriptive statistics and Chi-square tests were used to analyze quantitative data. Seventy-three participants completed the survey, with 47% representing independent pharmacies. The majority (96%) were interested in research opportunities and 86% believed improving workflow and patient care was the most valuable benefit. Eighty percent of pharmacists reported it is very important to demonstrate that pharmacists care about making patients’ health better. Connecting pharmacists with other health care providers was reported as very important by 75% of respondents. Pharmacists reported face-to-face communication (76%) as their preferred way to approach patients about research and 72% supported using student pharmacists to assist with patient engagement. The results from this study can inform others who are structuring processes and developing communication strategies for community pharmacy PBRNs, particularly in partnership with CINs.


2005 ◽  
Vol 39 (9) ◽  
pp. 1539-1541 ◽  
Author(s):  
Karen B Farris ◽  
Fernando Fernandez-Llimos ◽  
SI (Charlie) Benrimoj

Pharmaceutical care models and practices differ in various countries. Reimbursement for cognitive services, for example, varies across countries in Europe, Asia, and the Americas. Practice-based research has blossomed in many countries, with different emphases and challenges. This international series will describe the organization of community pharmacy within the healthcare system and report the status of practice-based research. Each paper will focus on one country. The series will conclude with a summary by the series editors describing the key themes across the papers, outlining milestones yet to be achieved, and proposing a research agenda for community pharmacy practice.


2018 ◽  
Vol 23 (6) ◽  
pp. 479-485 ◽  
Author(s):  
Jeremy S. Stultz ◽  
Chad A. Knoderer ◽  
Kalen B. Manasco ◽  
Jill A. Morgan ◽  
Hanna Phan

OBJECTIVES To evaluate the practice-based research network (PBRN) potential within the Pediatric Pharmacy Advocacy Group (PPAG) membership and to identify characteristics associated with member willingness to join a PPAG PBRN. METHODS In October 2016, a 21-question survey was sent by email to approximately 900 PPAG pharmacist members (excluding students) using contact information contained in the PPAG membership database. The survey elucidated information regarding training, clinical and research experience, practice site information, and willingness to participate in a PPAG PBRN. Descriptive statistics described the potential PBRN and multivariate logistic regression determined respondent characteristics associated with willingness to join the PBRN. RESULTS Of 145 survey respondents (a 16% survey response rate), 92 selected “yes” regarding their willingness to participate in the PPAG PBRN. Acute care general pediatrics was the most common area where respondents desired to perform research (44.6% of “yes” respondents), with over 2500 patients/day collectively available. The most common selected limitations to research were time and size of available patient populations (59.8% and 47.8% of “yes” respondents, respectively). Cumulative hours/week members would be willing to devote to the PBRN was approximately 77 to 206. Publication of a retrospective study (OR 10.4, 95% CI 2.1–51.9, p = 0.004), research protected time (OR 4.9, 95% CI 1.4–17.8, p = 0.015), and affiliation with an academic medical center (OR 3.32, 95% CI 1.05–10.45, p = 0.04) were independently associated with willingness (a “yes” response) to join a PPAG PBRN. CONCLUSIONS Within the PPAG membership, there is sufficient interest, expertise, patient exposure, and member time to develop a PBRN focused on pediatric pharmacotherapy. The identified characteristics associated with willingness to join the PBRN can help focus efforts for member involvement, education, and recruitment to ensure sustainability of the PPAG PBRN.


2018 ◽  
Vol 14 (4) ◽  
pp. 356-359 ◽  
Author(s):  
Donald G. Klepser ◽  
Michael E. Klepser ◽  
Jaclyn K. Smith ◽  
Allison M. Dering-Anderson ◽  
Maggie Nelson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document